Global Automated External Defibrillators Market

Automated External Defibrillators Market Size, Share, Growth Analysis, By Technology(Semi-Automatic, and Fully Automatic), By Key Sizes(Standard, and Pediatric), By End User(Hospital, Public Access, Emergency Medical Service, Homes), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2871 | Region: Global | Published Date: April, 2024
Pages: 217 | Tables: 90 | Figures: 72

Automated External Defibrillators Market News

  • In May 2023, Vithas and Shenzhen Mindray Bio-Medical Electronics Co Ltd formed a strategic cooperation. As per the agreement, Vithas has implemented cutting-edge patient monitoring technologies in all 20 of its facilities. Vithas was able to enhance patient safety in vital areas like intensive care units, operating rooms, post-anesthesia recovery units, and emergency rooms as part of the strategic relationship.
  • In April 2020, Philips kept up its adherence to the conditions of the FDA's consent decree, which is still in force and covers regular facility inspections and regulatory compliance monitoring for the company's other patient care businesses as well as the ECR division. The company started producing and distributing external defibrillators within the United States after receiving notification from the FDA that the ban on those operations has been removed.
  • In October 2023, by purchasing 80 cutting-edge Holters connected to a web server, the Murcia Health Service made a significant advancement in the treatment of patients suffering from palpitations, arrhythmias, and strokes. Cardiologists could read and interpret the examination results from any location, and the results would be automatically entered into the electronic patient record.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Automated External Defibrillator Market size was valued at USD 17 billion in 2022 and is poised to grow from USD 18.8 billion in 2023 to USD 39.1 billion by 2031, at a CAGR of 11% in the forecast period (2024-2031).

Intense competition among major competitors vying for market supremacy characterises the competitive environment of the automated external defibrillator market. firms with broad product portfolios and business alliances, such Philips Healthcare, ZOLL Medical Corporation, and Stryker Corporation, control large market shares. In this crucial medical device industry, up-and-coming companies like Physio-Control and Cardiac Science Corporation are also making noteworthy progress, encouraging innovation and boosting competitiveness. 'Nihon Kohden Corporation (Japan)', 'Asahi Kasei Medical Co., Ltd (Japan)', 'Cardiac Science Corporation (The U.S)', 'Zoll Medical Corporation (The U.S)', 'Koninklijke Philips N.V. (Netherlands)', 'Biotronik (Germany). GE Healthcare (The U.S)', 'Schiller AG (Switzerland)', 'Stryker Corporation (The U.S)', 'Mindray Medical International Limited (China)', 'Physio-Control Corporation (The U.S)', 'Metrax GmbH (Germany)', 'Boston Scientific Corporation', 'CU Medical Systems Inc.', 'Philips Healthcare', 'HeartSine Technologies (part of Stryker Corporation)', 'Welch Allyn (now part of Hillrom)'

With an electric shock to the heart, the automated external defibrillator can help restore abnormal cardiac rhythms, which is why it is becoming more and more popular. In the upcoming years, it is anticipated that the worldwide market for automated external defibrillators will offer revenue-generating potential due to the rising use of this device in the treatment of patients experiencing sudden cardiac arrest. Additionally, a rise in the number of smokers and alcohol addicts could open profitable business prospects.

Uprising in Automated External Defibrillators: Technology is advancing quickly in the industry. Artificial intelligence (AI), cloud connectivity, and smart features are just a few examples of how AEDs are being improved in terms of usability, accuracy, and connectivity to improve patient outcomes and enable remote monitoring.

The US and Canada make up the two largest segments of the North American market for automated external defibrillators. The largest market for automated external defibrillators is the United States. The market is primarily driven by a large population with diabetes, a significant growth in respiratory disorders, and a growing public awareness of respiratory diseases. For automated external defibrillators, the United States is expected to be the largest market because of several factors, including a rise in the prevalence of cardiovascular disease (CVDs). The market for automated external defibrillators is growing at the fastest rate in Asia Pacific as factors such increased rates of cardiovascular disease, developing healthcare systems, and government programmes that encourage public access to these life-saving equipment. Elevated adoption rates in the region can also be attributed to increased awareness and training initiatives.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

External Defibrillators Market
Buy Now GET FREE SAMPLE
Defibrillator Market
Buy Now GET FREE SAMPLE
Cardioverter Defibrillator Device Market
Buy Now GET FREE SAMPLE
Manual Resuscitators Market
Buy Now GET FREE SAMPLE
Cardiac Assist Devices Market
Buy Now GET FREE SAMPLE
Cardiac Rhythm Management Devices Market
Buy Now GET FREE SAMPLE
Medical Alert Systems Market
Buy Now GET FREE SAMPLE
Interventional Cardiology Devices Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Automated External Defibrillators Market

Report ID: SQMIG35A2871

$5,300
BUY NOW GET FREE SAMPLE